{
    "title": "Assessing the Reproducibility of Machine-learning-based Biomarker Discovery in Parkinson's Disease. (arXiv:2304.03239v1 [q-bio.GN])",
    "abstract": "Genome-Wide Association Studies (GWAS) help identify genetic variations in people with diseases such as Parkinson's disease (PD), which are less common in those without the disease. Thus, GWAS data can be used to identify genetic variations associated with the disease. Feature selection and machine learning approaches can be used to analyze GWAS data and identify potential disease biomarkers. However, GWAS studies have technical variations that affect the reproducibility of identified biomarkers, such as differences in genotyping platforms and selection criteria for individuals to be genotyped. To address this issue, we collected five GWAS datasets from the database of Genotypes and Phenotypes (dbGaP) and explored several data integration strategies. We evaluated the agreement among different strategies in terms of the Single Nucleotide Polymorphisms (SNPs) that were identified as potential PD biomarkers. Our results showed a low concordance of biomarkers discovered using different dat",
    "link": "http://arxiv.org/abs/2304.03239",
    "context": "Title: Assessing the Reproducibility of Machine-learning-based Biomarker Discovery in Parkinson's Disease. (arXiv:2304.03239v1 [q-bio.GN])\nAbstract: Genome-Wide Association Studies (GWAS) help identify genetic variations in people with diseases such as Parkinson's disease (PD), which are less common in those without the disease. Thus, GWAS data can be used to identify genetic variations associated with the disease. Feature selection and machine learning approaches can be used to analyze GWAS data and identify potential disease biomarkers. However, GWAS studies have technical variations that affect the reproducibility of identified biomarkers, such as differences in genotyping platforms and selection criteria for individuals to be genotyped. To address this issue, we collected five GWAS datasets from the database of Genotypes and Phenotypes (dbGaP) and explored several data integration strategies. We evaluated the agreement among different strategies in terms of the Single Nucleotide Polymorphisms (SNPs) that were identified as potential PD biomarkers. Our results showed a low concordance of biomarkers discovered using different dat",
    "path": "papers/23/04/2304.03239.json",
    "total_tokens": 976,
    "translated_title": "评估机器学习在帕金森病生物标记发现中的可重复性",
    "translated_abstract": "基因组关联性研究(GWAS)有助于发现在类似帕金森病(PD)等疾病的患者中较为普遍的遗传变异。因此，GWAS数据可以用于确定与该疾病相关的遗传变异。特征选择和机器学习方法可用于分析GWAS数据并识别潜在的疾病生物标志物。然而，GWAS研究存在技术差异，这些差异会影响识别的生物标记的可重复性，例如基因分型平台的差异以及选择被基因分型的个体的标准的不同。为了解决这个问题，我们收集了来自Genotypes and Phenotypes (dbGaP)数据库的五个GWAS数据集，并探索了几种数据集成策略。我们评估了不同策略在识别潜在PD生物标记物的单核苷酸多态性（SNP）方面的一致性。我们的结果显示，使用不同的数据集成策略发现的生物标记的一致性较低，这表明在使用机器学习方法识别基因生物标记时应谨慎报告。",
    "tldr": "本文评估了机器学习方法在生物标记发现中的可重复性，结果表明不同的数据集成策略在确定潜在PD生物标志物的SNPs上的一致性较低。",
    "en_tdlr": "This paper assessed the reproducibility of machine learning in biomarker discovery and found low concordance among different data integration strategies in identifying potential PD biomarkers through SNPs."
}